Market Research Blog – Page 1847 – New Product Development

Global Flexible Plastic Packaging Market Soars to New Heights: Projected to Reach USD 171.6 Billion by 2033

Future Market Insights (FMI) has released a new report projecting that the global flexible plastic packaging market will grow from US$ 108.3 billion in 2023 to US$ 171.6 billion by 2033, achieving a compound annual growth rate (CAGR) of 4.7% over the forecast period. This growth is fueled by increasing demand for packaged food items, advancements in eco-friendly packaging solutions, and the booming e-commerce sector.

Core Concepts in the Flexible Plastic Packaging Industry

Market Size (2023): Valued at US$ 36,978 million.
Growth Forecast (2023-2033): Expected to register a CAGR of 4.8%.
Historical Performance (2018-2022): Recorded a CAGR of 3.9%.
Limiting Factors: Lack of optimization in the e-packaging sector.
Leading Product Type: Films and wraps segment dominates the market.
Market Drivers:
1. Increasing demand for lightweight and durable packaging.
2. Growing e-commerce industry boosting packaging needs.
Regional Insights: Significant growth is anticipated in emerging markets, especially in Asia-Pacific.

Request Now to Unleash the Power of the Flexible Plastic Packaging Industry: https://www.futuremarketinsights.com/reports/sample/rep-gb-4174

E-Commerce Surge Boosts Flexible Packaging Demand

The COVID-19 pandemic underscored the critical role of flexible packaging in sustaining the global e-commerce sector. As the pandemic accelerated online shopping trends, the demand for flexible plastic packaging skyrocketed, opening up significant growth opportunities for the printing and packaging industry. This trend continues post-pandemic, with flexible packaging solutions becoming indispensable for businesses worldwide.

Sustainable Solutions Gain Traction

In response to growing environmental concerns, an increasing number of manufacturers are developing and promoting bio-based and sustainable flexible plastic packaging materials. The shift towards environmentally friendly packaging solutions is gaining momentum, with companies investing heavily in innovative technologies to meet global sustainability goals.

Rising Demand in Food and Beverage Industry

The rising demand for packaged food items is propelling the use of flexible plastic packaging materials such as polystyrene, polyethylene terephthalate, and polyethylene. High levels of export activity and investment in the food and beverage industries are expected to further drive the adoption of flexible plastic packaging solutions, ensuring longer shelf life and cost-effectiveness for a wide range of consumer goods.

Key Takeaways:

North America flexible plastic packaging market will grow at 3.0% CAGR during the assessment period owing to thriving e-commerce industry and increasing demand for convenient packaging solutions from restaurants and food services.
Europe market will exhibit a growth rate of 2.6% CAGR from 2021 to 2031, driven by increasing research on developing flexible bio-plastics and elevated export and production of flexible plastic packaging in the region.
Japan will hold more than 14% of the East Asia market in 2021, backed by increasing development in recycling infrastructure and limited usage of non-biodegradable plastics in the country.
Polylactic acid (PLA) bioplastics are gaining traction owing to their superior durability, recyclability and lightweight nature. The segment is predicted to expand by 1.11x of its current valuation over the assessment period.
General barrier packaging will account for more than 80% of the global market share by the end of 2031. Increasing demand for safe and sterile packaging options for packing vegetables and fruits will be the key growth driver.

Purchase Now to Access Segment-specific Information and uncover Key Trends, Drivers, and Challenges: https://www.futuremarketinsights.com/checkout/4174

Business Growth Opportunities:

Sustainable Packaging Solutions: The increasing focus on environmental sustainability presents an opportunity for the development and adoption of eco-friendly and biodegradable flexible plastic packaging materials.
Growing E-commerce Retailers: The thriving E-commerce market, particularly in the wake of the Covid-19 pandemic, is driving the demand for flexible plastic packaging solutions as online retailers strategically invest in eye-catching packaging to attract and retain customers.
Innovation in Materials: Advancements in polymer technology and material science offer opportunities for the creation of high-performance and customizable packaging solutions, meeting specific needs of different industries.
Rising Disposable Income in Emerging Markets: As disposable incomes rise in emerging economies, there is an expanding consumer base for packaged goods, driving the demand for flexible plastic packaging in various industries.
Customization and Personalization: The trend towards personalized and customizable packaging solutions provides an avenue for manufacturers to differentiate their products and cater to the evolving preferences of consumers.

Regional Market Insights

1. United States: The U.S. is expected to hold a significant share of 16.2%, valued at $4,648 million in 2023. The thriving e-commerce market, growing fast-food restaurant chains, and prominent end-use sectors such as personal care, healthcare, and pharmaceuticals are driving demand. The U.S. Census Bureau reported that retail e-commerce sales reached approximately US$ 215 billion in 2021, highlighting the significant role of e-commerce in the country’s economy.

2. India: India is experiencing significant growth in the flexible plastic packaging market due to government initiatives promoting eco-friendly packaging solutions. Innovations such as the Indian Institute of Technology’s development of a cost-effective and strong bioplastic are contributing to this growth.

Request For Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-4174

Key Companies Profiled

Amcor Ltd.
Constantia Flexibles Group GmbH
Berry Global Group, Inc.
Huhtamäki Oyj
Sonoco Products Company
Bemis Company, Inc.
Sealed Air Corporation
AR Packaging Group AB
Mondi Group
DS Smith Plc
CCL Industries Inc.

Key Segmentation:

By Material Type:

Oil Base Polymers
Bio-Plastics

By Product Type:

Pouches
Bags & Sacks
Tubes
Sleeve Labels
Films & Wraps

By Packaging Type:

VSP (Vacuum Skin Packaging)
MAP (Modified Atmospheric Packaging)
General Barrier

By End-Use:

Food
Beverages
Personal Care
Homecare
Pharmaceuticals
Industrial Packaging
Consumer Packaging
Others

By Region

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific excluding Japan (APEJ)
Japan
Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Mobile Sterile Units Market Poised for Growth, Projected to Reach USD 391.3 Million by 2033 at a 5.7% of CAGR

The global mobile sterile units market is set to experience substantial growth over the forecast period, driven by increasing awareness of hospital-acquired infections (HAIs) and the rising demand for sterile environments in healthcare settings. According to recent projections, the market is anticipated to grow at a compound annual growth rate (CAGR) of 5.7%, reaching a valuation of USD 391.3 million by the end of 2033, up from USD 214.6 million recorded in 2022.

Mobile sterile units play a crucial role in maintaining sterile conditions during clinical surgeries and medical procedures, thereby reducing the risk of HAIs associated with catheter use, improper hygiene practices, and antibiotic overuse. The market expansion is primarily driven by an increase in clinical surgeries worldwide and heightened emphasis on infection control measures in healthcare facilities.

Lead With Intelligence: Report Sample Awaits:
https://www.futuremarketinsights.com/reports/sample/rep-gb-10750

The increasing use of sterile units to prevent cross contamination in hospitals and clinics is one of the key reasons expected to drive the growth of the mobile sterile units market globally. Furthermore, patients and professionals find mobile sterile units more convenient because they are portable, which is contributing to the global market for mobile sterile units expanding over the coming years.

The growing awareness of hospital acquired infections is expected to fuel the growth of the mobile sterile unit market. As more surgical procedures require sterile equipment, the demand for mobile sterile units is growing. The need for mobile sterile units is increased by the fact that portable sterile units are lighter and require less floor space. Furthermore, throughout the course of the estimated time, it is anticipated that the market’s general expansion would be supported by the various applications for mobile sterile units in academic and research settings.

Competitive Landscape:

Prominent suppliers of mobile sterile units are focusing on geographical growth through acquisitions of local market companies in order to increase sales footprint and boost revenue in emerging economies. The three primary tactics suppliers employ to increase product sales across borders are distributor agreements, mergers and acquisitions, and strategic collaborations.

Recent Market Developments

In Feb 2020, Astell Scientific and Progressive Recovery, Inc. (PRI) collaborated to make PRI the exclusive USA sales and service dealer for Astell’s line of steam sterilizer autoclaves.
In June 2020, Tuttnauer introduced new novel products, including the T-Edge autoclave, TIVA-2 washer, and T-Clean line, to strengthen its infection control solutions.

Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the mobile sterile units market, which are available in the full report.

Obtain Our Methodology Details:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-10750

Key Companies Profiled:

Tuttnauer
Benchmark Scientific
Getinge Group
Belimed AG
Astell Scientific
Systec GmbH
Fedegari Autoclavi S.P.A.
Yamato Scientific Co. Ltd
Aller Innovations, Inc.
Hitech Ultraviolet Pvt. Ltd.
Renosem
Zhejiang FUXIA Medical Technology Co., Ltd.
Azbil group (Telstar)
Steris Plc
Steelco S.P.A
Mimic Medical Systems

Key Segments Covered in Mobile Sterile Units Industry Research:

By Product:

Steam Sterilizers
- Gravity Displacement Autoclave
- High-speed pre-vaccum sterilizer
Gaseous Sterilizer
- Ethylene oxide sterilizer
- Nitrogen dioxide sterilizer
- Chlorine dioxide sterilizer
- Ozone sterilizer
Ultraviolet Sterilizer
- Low pressure mercury lamp
- Pulsed Xenon Lamps
- Light-emitting diodes(LEDs)
Cold Plasma Sterilizers

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
The Middle East and Africa

In-Depth Market Insights: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/10750

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Acetaminophen Market Set for Steady Growth, Expected to Reach USD 15.2 Billion by 2033 at a 4.2% of CAGR

The global acetaminophen market, a key component of the pharmaceutical industry renowned for its pain-relieving properties, is poised for significant growth over the next decade. As of the end of 2022, the market is valued at USD 9.8 billion and is projected to expand at a compound annual growth rate (CAGR) of 4.2%, reaching USD 15.2 billion by the year 2033, according to a recent study by Future Market Insights.

Acetaminophen, also known as paracetamol, is widely recognized for its efficacy in managing pain and fever, making it a staple in both over-the-counter and prescription medications globally. The oral route of administration dominates the acetaminophen market, accounting for approximately 92.4% of the global market share in 2022.

The increasing prevalence of chronic pain conditions, growing awareness of pain management solutions, and the rising demand for over-the-counter analgesics are key factors driving market expansion. Additionally, the extensive use of acetaminophen in treating mild to moderate pain and its inclusion in various combination medications contribute to its sustained market growth.

Get your PDF Sample Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14325

Global Health Issues:

The field of pain management is intricately linked to worldwide health issues, particularly the profound effects of cancer. Given that 19.3 million people would be impacted by cancer globally in 2020, the National Cancer Institute’s finding that 20% to 50% of cancer patients experience pain highlights how important efficient analgesics are. The aging population is expected to add 21.7 million more cancer cases globally by 2030, increasing the need for trustworthy pain management treatments.

After-Opioid Epidemic Transition:

In the aftermath of the USA opioid epidemic, nations worldwide are recalibrating their approach to opioid prescribing. Governments in industrialized nations are championing the adoption of non-opioid analgesics, presenting a unique opportunity for businesses to pioneer cutting-edge non-opioid medications.

Key Takeaways:

Based on product type, the acetaminophen segment is projected to growt at a 4.1% CAGR through 2031.
The oral route of administration segment accounted for 92.4% of the total market share in 2021.
In terms of sales type, the OTC (over the counter) segment accounted for 91.6% of the global market share in 2021.
Sales through retail pharmacies will continue gaining traction. In 2021, the segment accounted for 28.5% of the total market share.
North America held the largest share of 33.0% of the global acetaminophen market in 2021, and the trend is expected to continue over the assessment period.

“Growing demand for self-aid and cost-effective OTC pain relievers, along with increasing usage of acetaminophen as the first line of treatment for pain management are the key factors projected to drive the market in the forthcoming years,” says the FMI analyst.

Competition Landscape:

Leading players operating in the global acetaminophen market are Abbott, Janssen Pharmaceuticals, Inc. [Johnson & Johnson], Bristol-Myers Squibb and Company, Cardinal Health Inc., Viatris, Procter & Gamble Company, Sanofi, Novartis AG, Bayer AG, Teva Pharmaceutical Industries Ltd, Perrigo Company, Mallinckrodt Pharmaceuticals, Glaxo SmithKline Pharmaceuticals Ltd, Sun Pharmaceutical Industries Ltd, and Sun Pharmaceutical Industries Ltd.

Some of the leading companies of the acetaminophen market are focusing on product launch collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence. For instance:

Johnson & Johnson, In March 2020, announced that it will be boosting up production of its flagship product Tylenol which is an over-the-counter pain killer
GlaxoSmithKline, In February 2020 was approval by the Food and Drug Administration for Advil Dual Action, with acetaminophen as an over-the-counter (OTC) product for pain relief.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-14325

Key Companies Profiled:

Pfizer Inc.
Sanofi
Janssen Pharmaceuticals.
Bayer AG
GlaxoSmithKline plc
Bristol-Myers Squibb and Company
Teva Pharmaceutical Industries Ltd
Cardinal Health Inc.
Perrigo Company.
Novartis AG
Sun Pharmaceutical Industries Ltd
Abbott
Mallinckrodt Pharmaceuticals
Procter & Gamble Company

Key Market Segments Covered in Acetaminophen Drugs Industry Research:

By Product:

Acetaminophen
Acetaminophen with Opioids
Others

By Route of Administration:

Oral
Injectable
Others

By Sales:

OTC (Over-the-counter)
Rx (Prescription)

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
E-commerce
Others

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

In-Depth Market Overview: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/14325

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Female Stress Urinary Incontinence Treatment Device Market is expected to grow steadily at a 6.4% annual rate and reach USD1.4 Billion by 2034 | FMI

Millions of women worldwide experience stress urinary incontinence (SUI), a condition causing involuntary urine leakage. Fortunately, the Female Stress Urinary Incontinence Treatment Device Market is on the rise, offering promising solutions. A recent market analysis highlights a current market value of USD 770.0 million in 2024. Looking ahead, the market is projected to experience significant growth, with a projected Compound Annual Growth Rate (CAGR) of 6.4% over the next decade. This translates to an anticipated market valuation of a substantial USD 1.432.0 million by 2034.

Several medical conditions, including enlarged prostate, muscle damage, excess urine formation, multiple sclerosis, Parkinson’s disease, spinal cord injury, and loss of storage capacity in the rectum, are anticipated to contribute to the growing incidence of stress urinary incontinence among women. This increasing prevalence is a key driver behind the escalating demand for female stress urinary incontinence treatment devices.

The landscape of female stress urinary incontinence treatment has evolved significantly over the past decade. The number of procedures performed has witnessed a notable increase, with a remarkable shift in the relative numbers of different procedures. Notably, in England, there has been a 28% surge in the annual number of operations involving female stress urinary incontinence treatment devices between 1997-1998 and 2005-2006. This growth is particularly noteworthy considering a reduction of over 90% in the number of colposuspension and needle suspension procedures during the same period.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-2533

Healthy Revenue Growth Projected Through 2029

According to the latest research by FMI, the Global Female Stress Urinary Incontinence Treatment Device Industry is estimated to have accounted for ~ US$ 560 Mn in terms of value in 2018. The report on the female stress urinary incontinence treatment devices industry further projects that the female stress urinary incontinence treatment devices Industry is likely to grow at a CAGR of ~ 6% during the period 2019-2029.

However, due to the presence of a wide range of products in the female stress urinary incontinence treatment devices Industry, small players are gaining interest and are selling their products at a lower price. An increase in the penetration of private-label brands at much lower prices is expected to decrease the average overall price of female stress urinary incontinence treatment devices. This is likely to restrain the growth of the global female stress urinary incontinence treatment devices industry, as it is likely to hamper the demand for expensive products.

Rapid changes have taken place in developing countries over the past few years. The improper implementation of regulatory guidelines and the lack of proper healthcare infrastructure in developing regions, such as the Middle East & Africa and Latin America, are among the factors that are expected to restrain the growth of the female stress urinary incontinence treatment devices Industry.

50% Revenue Shares Accounted by North America

The Global Female Stress Urinary Incontinence Treatment Device Industry has been analysed across the regions of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa. North America, followed by Europe, is a prominent region in the global female stress urinary incontinence treatment devices Industry. North America accounted for a revenue share of about 50% in 2018 in the female stress urinary incontinence treatment devices Industry. Europe also accounted for a prominent revenue share and is followed by East Asia in the female stress urinary incontinence treatment devices Industry.

The Global Female Stress Urinary Incontinence Treatment Device Industry report tracks some of the key companies operating in the female stress urinary incontinence treatment devices industry, such as Boston Scientific Corporation, BD, Coloplast Corporation, Caldera Medical, and Ethicon US LLC (Johnson & Johnson Services, Inc.). The majority of the key regional players in the female stress urinary incontinence treatment devices industry are highly focused on expanding their product connectivity and reach with the help of domestic distributors of female stress urinary incontinence treatment devices. Moreover, the manufacturers of female stress urinary incontinence treatment devices are focused on strengthening their businesses in high-growth markets, such as India, Japan, and China, by expanding their distribution and sales channels.

Purchase The Full Report Now!
https://www.futuremarketinsights.com/checkout/2533

Key Segments Of Female Stress Urinary Incontinence Treatment Device Market Survey female stress urinary incontinence treatment devices Industry by Product Type:

Sling Systems
- Mid-Urethral Slings
- Sub-Urethral Slings
Pessaries
Artificial Urinary Sphincters (AUS)
Injectable Urethral Bulking Agents

Female Stress Urinary Incontinence Treatment Device Market by End Use:

Female Stress Urinary Incontinence Treatment Devices for Hospitals
Female Stress Urinary Incontinence Treatment Devices for Gynaecological Clinics
Female Stress Urinary Incontinence Treatment Devices for Homecare Settings

Female Stress Urinary Incontinence Treatment Device Market by Region:

North America Female Stress Urinary Incontinence Treatment Devices Market
Latin America Female Stress Urinary Incontinence Treatment Devices Market
Europe Female Stress Urinary Incontinence Treatment Devices Market
East Asia Female Stress Urinary Incontinence Treatment Devices Market
South Asia & Pacific Female Stress Urinary Incontinence Treatment Devices Market
Middle East & Africa (MEA) Female Stress Urinary Incontinence Treatment Devices Market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments based on Source, Application, Sales Channel and End Use over the next 10 years.

Contact Us:

Venous Thromboembolism Treatment Market Is Anticipated to Reach USD 2.58 Billion by 2034, with a Consistent 3.9% CAGR | FMI

There’s encouraging news in the battle against blood clots. The global Venous Thromboembolism Treatment Market, valued at USD 1.76 billion in 2024, is expected to reach a substantial USD 2.58 billion by 2034. This signifies a steady growth trajectory at a Compound Annual Growth Rate (CAGR) of 3.9% over the next decade.

Venous Thromboembolism, a medical condition characterized by the formation of blood clots in deep veins, is a significant concern in the healthcare landscape. The FMI study highlights that more than 60% of the demand for VTE treatment is attributed to deep venous thrombosis, underlining the pressing need for effective treatment solutions in this domain.

Venous thromboembolism treatment involves segmented pneumatic compression pumps without gradient, segmented pneumatic compression pumps with calibrated gradient, lower pneumatic compression sleeves, non-segmented pneumatic compression pumps permanent inferior vena cava filters, retrievable inferior vena cava filters, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (CDT) devices and upper pneumatic compression sleeves. Based on the disease indication, deep vein thrombosis is expected to hold a prominent share in the overall Global Venous Thromboembolism Treatment Industry.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-1341

Poor Reimbursement Scenario Against High Treatment Costs to Restrict Adoption

Several factors are impacting the overall growth of the Global Venous Thromboembolism Treatment Industry. The first and the most important factor driving the Global Venous Thromboembolism Treatment Industry is the increasing prevalence of venous thromboembolism disease. Other factors, such as the increasing retrieval rate of vena cava filters, increasing healthcare awareness, presence of favourable reimbursement policies, and increasing geriatric population, are also responsible for the growth of the Global Venous Thromboembolism Treatment Industry.

Apart from the driving factors of the Global Venous Thromboembolism Treatment Industry, there are few factors that are likely to hinder the overall growth of the venous thromboembolism treatment market. The high cost associated with venous thromboembolism treatment therapy, poor reimbursement for some of the treatment devices, and poor insurance support are among the major factors that are expected to hamper the growth of the Global Venous Thromboembolism Treatment Industry.

Drug-based Treatment Witnessing Traction across Europe

Although increasing preference for drug-based venous thromboembolism treatment is highly likely to hinder the growth of the market, new-generation drugs, including non-Vitamin K antagonist oral anticoagulants (NOACs) such as dabigatran, rivaroxaban, apixaban, and edoxaban, are estimated to boost the adoption rate of venous thromboembolism treatment due to increased efficacy. However, there are regional variations to this trend.

North America is expected to be a prominent region in the Global Venous Thromboembolism Treatment Industry because of the presence of a well-developed healthcare infrastructure and numerous technological advancements in the region. The increasing prevalence of venous thromboembolism is also responsible for the boosting the growth of the North America market. Treatment using mechanical and interventional prophylaxis systems is expected to be increasingly adopted in the North American region during the forecast period. In addition, drug-based treatment is expected to gain popularity in the European region, which is expected to subsequently decrease the usage of mechanical and interventional treatments in the region.

On the other hand, increasing per capita healthcare expenditure is one of the macroeconomic factors that is likely to boost the market. Nowadays, certain changes in the socio-economic scenario can also lead to significant growth in the Global Venous Thromboembolism Treatment Industry.

Tier 1 Players Account for Nearly 35% Market Revenue Share

Some of the key manufacturers of venous thromboembolism treatment are mainly focusing on innovating and launching new and advanced products. Major players in the Global Venous Thromboembolism Treatment Industry are focusing on collaborations and acquisitions. For example, venous thromboembolism treatment is majorly adopted by hospitals, catheterization laboratories, and ambulatory surgical centers. Hospitals are expected to hold a significant revenue share in the venous thromboembolism treatment market.

The report tracks some of the key companies operating in the Global Venous Thromboembolism Treatment Industry such as ArjoHuntleigh AB, AngioDynamics, Cardinal Health Inc., BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, and Teleflex Inc., Boston Scientific Corp. several other companies are operating in the Global Venous Thromboembolism Treatment Industry. AngioDynamics, Boston Scientific Corp., and Cardinal Health Inc. are expected to hold a prominent share in the venous thromboembolism treatment market. These tier 1 companies hold a share of approximately 35% in the Global Venous Thromboembolism Treatment Industry.

Access Exclusive Market Insights – Purchase Now!
https://www.futuremarketinsights.com/checkout/1341

Venous Thromboembolism Treatment Market by Category By Product:

Non-Segmented Pneumatic Compression Pumps
Segmented Pneumatic Compression Pumps without Gradient
Segmented Pneumatic Compression Pumps with Calibrated Gradient
Upper Pneumatic Compression Sleeves
Lower Pneumatic Compression Sleeves
Permanent Inferior Vena Cava Filters
Retrievable Inferior Vena Cava Filters
Embolectomy Balloon Catheters
Percutaneous Thrombectomy Devices
Catheter-Directed Thrombolysis (CDT) Devices

By Disease Indication:

Deep Venous Thrombosis
Pulmonary Embolism

By End User:

Hospitals
Catheterisation Laboratories
Ambulatory Surgical Centers

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Fanfold Market Poised for Growth, Forecasted to Reach USD 41.58 Billion by 2032 at a 4.5% of CAGR

The global fanfold market is expected to witness significant growth in the coming decade, driven by increasing applications across various industries and advancements in packaging and printing technologies. According to recent market analysis, the market, valued at USD 29.48 billion in 2022, is anticipated to grow at a steady compound annual growth rate (CAGR) of 4.5%, reaching a valuation of USD 41.58 billion by 2032.

Fanfold products are versatile and widely used in packaging, printing, and labeling applications due to their convenience, cost-effectiveness, and sustainability benefits. The market’s growth is bolstered by the expanding e-commerce sector, increasing demand for efficient packaging solutions, and advancements in manufacturing processes.

Moreover, due to the rising sales of fanfold products and increased manufacturing activities, Brazil and Mexico in the Americas are likely to experience above-average growth in the fanfold market. These regions are expected to be pivotal in the global fanfold market’s expansion, reflecting the increasing demand for reliable packaging solutions in the industrial and e-commerce sectors.

Request for a Sample of this Research Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-10051

The Major Key Players Are:

Box on Demand,
International Paper Company,
Smurfit Kappa,
DS Smith,
Menasha Packaging Company,
Papierfabrik Palm,
Braepac Packaging,
Independent Corrugator,
Rondo Ganahl,
RIBBLE PACKAGING LTD.

Market Drivers:

Growing Demand:
- A key driver for any market is an increasing demand for the product or service. If the fanfold market serves a particular need or has unique advantages, a growing demand for such products could be a significant driver.
Technological Advancements:
- Innovation and technological advancements in fanfold products could boost market growth. For instance, if there are improvements in printing technologies, packaging materials, or other related areas, it can drive the demand for fanfold products.
Environmental Sustainability:
- Increasing awareness and focus on environmental sustainability can drive the demand for eco-friendly or recyclable fanfold products. If fanfold solutions align with sustainable practices, it could be a market driver.
Efficiency and Cost Savings:
- If fanfold products offer cost-effective and efficient solutions compared to alternatives, businesses might adopt them to improve their operational efficiency.
Regulatory Support:
- Supportive regulations or policies that favor the use of fanfold products can act as a driver. This could include regulations related to packaging materials, printing practices, or other relevant factors.

Market Restraints:

Competition from Alternatives:
- If there are alternative products or technologies that offer similar or better benefits, the fanfold market might face challenges in gaining and maintaining market share.
Economic Downturn:
- Economic downturns can impact overall business activities, and companies may cut down on non-essential expenses, affecting the demand for fanfold products.
Raw Material Price Volatility:
- If the production of fanfold products is heavily dependent on certain raw materials, fluctuations in the prices of these materials can impact profit margins and the overall market.
Lack of Awareness:
- If potential customers are not aware of the benefits or applications of fanfold products, it could limit market growth. Effective marketing and education campaigns might be needed to address this restraint.
Stringent Regulations:
- Conversely, stringent regulations that increase compliance costs or limit certain features of fanfold products can act as a restraint on the market.

Recent Developments:

Smurfit Kappa Group finalised the acquisition of Verzuolo in October 2021. In 2019, the business transformed the PM9 machine into a cutting-edge 661,387-ton recycled containerboard machine as a result of this acquisition. It supplements the already existing and ideally positioned operational facilities near Savona’s port. This is likely to benefit both the corporation and its customers.
Rengo Co., Ltd. announced in September 2021 that its joint venture in Vietnam, Vina Kraft Paper Co., Ltd., had chosen to develop a new containerboard production site. Vietnam’s overall annual demand for containerboard exceeded three million tonnes in 2019 as a result of ongoing foreign direct investment, primarily in the export industry, and rising domestic consumption.

Key Offerings of the Report

Growth Drivers and Opportunities: Comprehensive analysis on growth-driving factors and opportunities for market players in different regional markets
Recent Trends and Forecasts: Detailed assessment on the latest trends, technological developments, and forecasts for a 5-year or 10-year period.
Segmental Analysis: Extensive analysis on each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis
Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with necessary information to take critical decisions
Competitive Landscape: All-inclusive insights on both leading and emerging players vying for a slice of the Fanfold market

Seize the Opportunity: Get Report Now for a Thorough Report:
https://www.futuremarketinsights.com/checkout/10051

Key Segmentation:

On the basis of wall type

Single-walled
B flute
C flute
Double-walled
BC flute
EB flute

On the basis of width

200 mm – 500 mm
500 mm – 1000 mm

About Future Market Insights (FMI)

Contact Us:

Mucopolysaccharidosis Treatment Market is expected to reach USD 3.37 Billion by 2029, growing at a 5.9% CAGR | FMI

There’s positive news for those battling Mucopolysaccharidosis (MPS), a rare group of genetic disorders. The Mucopolysaccharidosis Treatment Market is experiencing significant growth, projected to reach a substantial USD 3.37 billion by 2029. This signifies a strong CAGR (Compound Annual Growth Rate) of 5.9%, building on a market value of roughly USD 2.38 billion in 2022.

According to research, the mucopolysaccharidosis treatment is still emerging, and different geographies have implemented standard treatment options for the condition. However, there is no universally accepted treatment pattern for mucopolysaccharidosis. Mucopolysaccharidosis falls under rare diseases, which is a complex, diverse, and constantly evolving field, and there is a significant shortage of medical and scientific data related to it. Mucopolysaccharidosis treatment and diagnosis involve complex management requirements, which include long-term care, rehabilitation support, and a continuous treatment plan.

A market study presented by FMI ‘Mucopolysaccharidosis Treatment Market Trend: Global Industry Analysis 2014-2021 and Opportunity Assessment 2022-2029,’ explains the significant factors influencing the current market structure.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5880

Research Activities Uplift Stem Cell Therapy Application in Mucopolysaccharidosis Treatment Market

In the present scenario, the drugs that are considered for mucopolysaccharidosis treatment, such as aldurazyme, naglazyme, vimizim, elaprase, mepsevii and hunterase, are the only regulated and recommended drugs present in the market. These drugs fall under enzyme replacement therapies, however, with present research initiatives for stem cell therapies, the latter is considered a prominent mucopolysaccharidosis treatment. Clinical research shows that stem cell transplantation covers a large area that is not covered with the more frequently recommended practice of enzyme replacement therapies, which changes the current market structure for mucopolysaccharidosis treatment, prioritizing the latter.

Stem cell therapy is a therapeutic option for mucopolysaccharidosis patients suffering from a severe phenotype, as research shows the method can preserve neurocognition or can even help break the progressive neurodegeneration. The method is provided with strict selection criteria, which is followed by maintained regulations. Research shows that stem cell therapy as a treatment option is gaining popularity among healthcare professionals for mucopolysaccharidosis treatment, which can be attributed to the relation of its better reach towards a normal health condition for the patient.

Enzyme Replacement Therapy Remains Lucrative for Market Investors

As per further assessments of the mucopolysaccharidosis treatment market, it has been difficult to collect epidemiological data about rare diseases, especially mucopolysaccharidosis treatment, which is likely to impede the actual estimation of the economic burden associated with the condition. The cost estimation for each mucopolysaccharidosis treatment type is affecting and, in turn, creating a more vulnerable situation for the businesses and disrupting research & development activities for each company.

Enzyme replacement therapy is the most attractive segment for investors, however, the unavailability of reimbursement plans and precise treatment plans is encouraging most patients in developing regions to opt for symptomatic treatments instead of enzyme replacement therapy, which is still considered to be the standard mucopolysaccharidosis treatment.

Key Players Focus on Clinical Research of Treatment Models

The report segments the mucopolysaccharidosis treatment market into seven regions to elaborate on the regional trends of the treatment plan. Major players are focusing on increasing their market share in the Asia Pacific market through strategic collaborations with regional research institutes. There is a lack of awareness about rare diseases among the general public as well as in medical healthcare facilities in several emerging economies. According to a survey and industry report, it takes patients in the US an average of 7.6 years and patients in the UK an average of 5.6 years to actually receive a proper diagnosis. Moreover, it involves a team of healthcare professionals to actually get the right mucopolysaccharidosis treatment and diagnosis pattern for reported cases.

Manufacturers are in the process of introducing a considerable number of mucopolysaccharidosis treatment options, which are currently under clinical trials. An estimated 160 and above clinical trials are being performed for mucopolysaccharidosis treatment. Thus, ensuring that the manufacturers take this mucopolysaccharidosis treatment market to be lucrative and potential rich in terms of revenue. Medical research institutes play an important role in this particular market. They are expected to be the bridge between treatment plans and economical solutions for manufacturers, thus leaving an explicable and lucrative model for mucopolysaccharidosis treatment.

Request Your Customized Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-5880

The mucopolysaccharidosis treatment market includes companies such as BioMarin Takeda Pharmaceutical Company Limited, Sanofi S.A., and Ultragenyx Pharmaceutical Inc. BioMarin accounts for a significant value share in the present mucopolysaccharidosis treatment market. The currently existing promising drug types are expected to face competition from emerging candidates. In addition, the mucopolysaccharidosis treatment products of other companies, such as Sangamo Therapeutics, Inc., REGENXBIO Inc., Sarepta Therapeutics, Abeona Therapeutics, Inc., and others, are also in the pipeline.

Mucopolysaccharidosis Treatment Market by Category Treatment

Enzyme Replacement Therapies
Stem Cell Therapies
- Bone Marrow Transplantation
- Umbilical Cord Blood Transplantation

Type of MPS

MPS I
MPS II
MPS IV A
MPS VI
MPS VII

End User

Hospital
Specialty Clinics
Medical Research Centers
Home-infusion

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Commercial Paper Bags Market Set for Robust Growth USD 13.0 Billion by 2033 at a 7.5% of CAGR

The global market for commercial paper bags market is poised for substantial growth in the coming decade, driven by continuous innovations in paper bag technology and increasing consumer preference for sustainable packaging solutions. According to a recent market analysis, the market size is expected to reach USD 6.3 billion in 2023 and is projected to grow at a strong compound annual growth rate (CAGR) of 7.5%, reaching approximately USD 13.0 billion by 2033.

Commercial paper bags serve as eco-friendly alternatives to plastic bags across retail, food service, and grocery sectors, offering benefits such as biodegradability, recyclability, and brand customization. As businesses and consumers alike prioritize sustainability and environmental responsibility, the demand for innovative paper bag solutions continues to rise globally.

Request for a Sample of this Research Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-9312

Dynamics:
The strong demand from the retail industry is anticipated to propel the global market for commercial paper bags. Commercial paper bags are reusable, portable, and light in weight. This has been identified as a crucial element in their customer uptake. Other than retail, commercial paper bags are also used extensively in the building & construction industry, especially for heavy-duty applications.

The impact is expected to be more intense in regions such as the Asia Pacific and the Middle East. In the Asia-Pacific region, there has been a substantial growth in the number of real estate and infrastructure development projects in the past few decades. This is expected to bolster the demand for commercial paper sacks in the coming year

Growth Factors:

Environmental Awareness and Plastic Bans: Increasing global concern about environmental issues, coupled with government initiatives to ban or restrict single-use plastics, is driving the demand for eco-friendly alternatives like commercial paper bags.
Innovations in Paper Bag Technology: Ongoing advancements in the design and manufacturing of paper bags, including improvements in durability, printing techniques, and customization options, are attracting businesses and consumers towards paper bag solutions.
Corporate Sustainability Initiatives: Many businesses are adopting sustainable practices, including the use of environmentally friendly packaging. Commercial paper bags align with corporate sustainability goals, leading to a growing preference for such packaging solutions.
Consumer Preference for Eco-Friendly Packaging: As consumer awareness about the environmental impact of plastic grows, there is a shift in preferences toward sustainable and biodegradable packaging options, driving the demand for commercial paper bags.
Global Expansion of Retail and E-commerce: The expanding retail sector and the rise of e-commerce globally contribute to increased demand for packaging solutions. Commercial paper bags are favored for their versatility, branding opportunities, and eco-friendly appeal.

Request Report Methodology:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-9312

Industry Trends in the Commercial Paper Bags:

Customization and Branding: Companies are increasingly using commercial paper bags as a means of branding and marketing. Customized designs, logos, and messages on paper bags contribute to brand visibility and customer engagement.
Emphasis on Recyclability and Biodegradability: With a growing focus on sustainability, there is a trend towards commercial paper bags that are not only recyclable but also biodegradable, aligning with circular economy principles.
Digital Printing Technologies: The adoption of advanced digital printing technologies allows for intricate and high-quality printing on paper bags. This trend enhances the visual appeal of bags, providing opportunities for unique and eye-catching designs.
Collaborations for Sustainable Supply Chains: Businesses in the commercial paper bags market are forming partnerships and collaborations to create sustainable supply chains. This involves sourcing raw materials responsibly and ensuring ethical and eco-friendly production processes.
E-commerce Packaging Solutions: With the rise of online shopping, there is a trend towards developing commercial paper bags tailored for e-commerce packaging. These bags not only serve as carriers but also play a role in enhancing the overall unboxing experience for consumers.

Key Players:

Examples of some of the key players operating in the global market are Smurfit Kappa Group Plc., Essentra Plc., Novolex Holdings, Inc., Mondi Group plc, International Paper Company, United Bags, Inc., El Dorado Packaging, Inc., and Langston Companies, Inc. among others.

Seize the Opportunity: Get Report Now for a Thorough Report
https://www.futuremarketinsights.com/checkout/9312

Market Segmentation

Based on product type

Sewn open mouth bags
Pinched bottom open bags,
Pasted valve bags,
Pasted open mouth bags
Flat bottom bags

Based on material type,

Brown Kraft
White Kraft

Based on thickness,

2 ply
3 ply
>3 ply

Based on end-uses

Agricultural & allied industries
Building & construction
Food & beverage
Retail
Chemical industry
Others

About Future Market Insights (FMI)

Contact Us:

Electronic Stethoscope Market is anticipated to reach USD 528.2 Million by 2034, growing at a 6.10%. of CAGR | FMI

The medical field is experiencing a shift in how doctors listen to their patients’ hearts and lungs. A new report by Future Market Insights (FMI) forecasts significant growth in the Electronic Stethoscope Market, reaching a projected value of USD 528.2 million by 2034. This substantial increase builds on a current market valuation of USD 292.2 million in 2024, reflecting a steady Compound Annual Growth Rate (CAGR) of 6.10%.

Key Manufacturers Continue to Strategize on New Product Launches in Electronic Stethoscopes Landscape

Almost 2/5^th of total adoption of electronic stethoscopes is registered at hospitals, the report underscores that there has been significant adoption by medical institutes in the recent past. In the next few years, medical institutes and ambulatory surgical centers are likely to create multiple opportunities for manufacturers of electronic stethoscopes.

More than half of the overall sales is accounted by amplifying electronic stethoscopes, as indicated by FMI’s analysis. While amplifying electronic stethoscopes provide results as accurate as digitizing electronic stethoscopes, the latter are associated with high maintenance owing to the presence of multiple electronic components. Amplifying electronic stethoscopes are thus expected to observe significant growth in revenue over coming years.

Get Sample Report + Related Graphs & Charts
https://www.futuremarketinsights.com/reports/sample/rep-gb-9457

According to the report, the market attractiveness of amplifying stethoscopes is strongly backed by the increasing number of launches of new electronic stethoscopes by some small- and medium-sized companies. Electronic stethoscopes are rapidly replacing conventional variants across developed countries, predominantly owing to accelerated regulatory approvals.

eKuore had launched the first wireless stethoscope for medical use.
Eko had launched the first Android–connected digital stethoscope.
In April 2018, Steth IO launched a digital smartphone-enabled stethoscope.

According to the report, approximately 60% of the electronic stethoscopes that are sold are enabled with Bluetooth technology and an integrated chest piece system. The former is however poised to witness a higher rate of adoption over the coming years.

North America Continues to Lead the Electronic Stethoscope Market

North America holds a considerable revenue share in the electronic stethoscopes market. With advancements in technology and the presence of a large number of healthcare facilities, electronic stethoscopes are being widely used in the region. Their ability to provide amplified sound output as well as reduce external sound makes it easy for medical professionals to detect sounds and provide proper treatment to patients.

FMI’s study has profiled some of the key companies operating in the global electronic stethoscopes market, including Eko Devices, eKuore, GlobalMed, 3M, Welch Allyn, Ambisea Technology Corp., Meditech Equipment Co., Ltd, HD Medical, Thinklabs, ADInstruments, and Cardionics Inc.

Purchase the Full Report!
https://www.futuremarketinsights.com/checkout/9457

Electronic Stethoscope Market by Category Product:

Amplifying Stethoscopes
Digitizing Stethoscopes

End User:

Hospitals
Clinics
Medical Institutes
Ambulatory Surgical Centers
Homecare Settings
Medical Camps
Catheterization Laboratories

Application:

Integrated Chest-Piece System
Wireless Transmission System (Bluetooth)
Integrated Receiver Head-Piece System
Other

Author by

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Paper Release Liners Market Poised for Strong Growth USD 50.9 Billion by 2033 at a 6.5% of CAGR

The global market for paper release liners market is set to experience significant growth in the coming decade, driven by advancements in automation and increasing applications across various industries. According to the latest market analysis, the market size is expected to reach USD 27.1 billion in 2023 and is projected to expand at a robust compound annual growth rate (CAGR) of 6.5%, reaching approximately USD 50.9 billion by 2033.

Paper release liners play a crucial role in various industries, including packaging, labels, medical, and construction, by providing a protective layer and facilitating easy release of adhesive materials. The integration of release liners with automated manufacturing processes is enhancing efficiency, reducing production time, and lowering operational costs, thereby driving market demand.

The burgeoning demand for packaged and ready-to-eat food products in the region is a driving force. The increasing working population and a growing trend of single living are reshaping consumer preferences. The ready availability of convenient, ready-to-cook packaged foods and the rising consumption of thermoformed container-packed fresh products, including fruits and vegetables, are creating a surge in the need for labels and food quality stickers. Consequently, this trend is boosting the sales of paper release liners in the market.

Request for a Sample of this Research Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-9088

In addition to the food industry, the automotive sector is another significant contributor to the demand for paper release liners. Automotive manufacturers are progressively shifting from conventional mechanical fasteners to automotive adhesive tapes. This transition is motivated by the desire to reduce production time, cut costs, and decrease automobile weight. As the demand for lightweight and fuel-efficient vehicles escalates, driven by rising fuel prices, it further favors the sales of paper release liners in the Asia Pacific (excluding Japan) market.

One of the major factors contributing to the growth of the paper release liners market is the explosive growth of e-commerce, which has revolutionized the way products are packaged, labeled, and delivered. The importance of clear and accurate labeling to facilitate tracking, handling, and unboxing has increased, as online shopping becomes more prominent. Paper release liners play a critical role in ensuring that labels are applied without complications, contributing to a smooth and reliable e-commerce experience.

Industries are seeking sustainable packaging alternatives, as environmental awareness and concerns about plastic waste intensify. Paper release liners are highly sustainable, being derived from renewable resources and being fully recyclable and biodegradable. Brands looking to adopt eco-friendly practices are turning to paper release liners as part of their commitment to reducing their environmental impact.

Ongoing advancements in printing, labeling, and adhesive technologies are driving the demand for more sophisticated paper release liners. The advancements ensure compatibility with various printing methods, including digital and flexographic printing, allowing for intricate designs and customization. Improved adhesive formulations also contribute to better label application efficiency.

Key Takeaways from the Market Study

Global paper release liners market was valued at US$ 25.5 billion by 2022-end.
From 2018 to 2022, the market demand expanded at a CAGR of 3.1%.
Asia Pacific excluding Japan is expected to hold a dominant CAGR of 6.4% during the forecast period.
By substrate, silicone-coated paper segment is expected to constitute a CAGR of 6.4% in 2033.
On the basis of application, labels segment is expected to dominate the market with a CAGR of 6.4% in 2033.
From 2023 to 2033, Paper Release Liners market is expected to flourish at a CAGR of 6.5%.
By 2033, the market value of Paper Release Liners is expected to reach US$ 50.9 billion.

“Regulatory compliance, across the globe, is a major factor that is expected to propel the growth of the paper release liners market in the near future” – remarks an FMI analyst.

Factors Driving the Market for Paper Release Liners

Consumer Demand for Convenient Packaging : The growing preference for packaged and ready-to-eat food products, driven by factors like an expanding working population and the rise of single-person households, fuels the demand for paper release liners in the packaging industry.
Shift in Automotive Manufacturing : Automotive manufacturers are increasingly adopting automotive adhesive tapes over traditional mechanical fasteners to reduce production time, cut costs, and lower the weight of vehicles, aligning with the rising demand for lightweight and fuel-efficient automobiles.
Fuel Price Dynamics : The surging fuel prices are pushing the automotive industry towards lightweight and fuel-efficient vehicles, which, in turn, contributes to the increased use of paper release liners as part of the manufacturing process.
Sustainable Packaging Solutions : The market for paper release liners benefits from the growing emphasis on sustainability in packaging materials and practices, as paper is a biodegradable and eco-friendly option.
Food Quality and Labeling Requirements : The need for labels and food quality stickers for products like thermoformed container-packed fresh produce and ready-to-cook foods is fostering the use of paper release liners in the food industry.
Asia Pacific’s Dominance : The Asia Pacific region, excluding Japan, is expected to play a pivotal role in driving the global market for paper release liners, with significant demand emanating from its diverse consumer and automotive sectors.

Competitive Landscape

Prominent players in the Paper Release Liners market are

Avery Dennison Corporation,
Mondi Group,
Fox River Associates, LLC,
3M,
Loparex Holding B.V.,
Gascogne Group,
UPM,
Rayven Inc.,
Quanjiao Guangtai Adhesive Products Co. Ltd., and
Elkem Silicones,
among others.

Recent Developments:

In 2021, Duraco Specialty Tapes acquired Rayven, Inc., a developer and manufacturer of coated functional films, specialty tapes, and niche release liners.
In 2020, Mondi introduced NextLiner, a first-to-market release liner solution that uses polymers derived from renewable resources and recycled base paper.
In 2020, Loparex launched a new line of high-performance release liners for the electronics and medical device industries.

Buy this Report Now:
https://www.futuremarketinsights.com/checkout/9088

Key Segments Profiled In The Global Paper Release Liners Market

By Substrate:

Poly-coated Paper
Silicone-coated Paper
Glassine, Clay-coated Paper

By Labelling Technology:

In-mold
Pressure Sensitive
Adhesive Applied
Sleeving

By Application:

Graphic Arts
Labels
Automotive
Construction
Medical & Hygiene
Industrial
Tapes
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
South Asia and Pacific
East Asia
Middle East and Africa (MEA)

About Future Market Insights (FMI)

Contact Us: